Form 8-K - Current report:
SEC Accession No. 0001654954-23-003722
Filing Date
2023-03-28
Accepted
2023-03-28 16:06:16
Documents
14
Period of Report
2023-03-28
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 FORM 8-K drma_8k.htm   iXBRL 8-K 25549
  Complete submission text file 0001654954-23-003722.txt   165023

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA drma-20230328.xsd EX-101.SCH 6017
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE drma-20230328_lab.xml EX-101.LAB 16514
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE drma-20230328_cal.xml EX-101.CAL 898
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE drma-20230328_pre.xml EX-101.PRE 12073
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE drma-20230328_def.xml EX-101.DEF 3984
8 EXTRACTED XBRL INSTANCE DOCUMENT drma_8k_htm.xml XML 4987
Mailing Address 3525 DEL MAR HEIGHTS RD., #322 SAN DIEGO CA 92130
Business Address 3525 DEL MAR HEIGHTS RD., #322 SAN DIEGO CA 92130 (858)-223-0882
Dermata Therapeutics, Inc. (Filer) CIK: 0001853816 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40739 | Film No.: 23769534
SIC: 2834 Pharmaceutical Preparations